Ocean Biomedical, Inc.
OCEA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001869974
No open-market purchases or sales by Ocean Biomedical, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Ocean Biomedical, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −14 vs. Q2 2024
- Shares held
- 3.58M
- −275.5K (−7.1%) vs. Q2 2024
- Total value
- $3.46M
- −$1.19M (−25.5%) vs. Q2 2024
- New holders
- 4
- 2 more added
- Sold out
- 18
- 11 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OCEA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 7 | $5.69K |
| Q1 2025 | 25 | $247.3K |
| Q4 2024 | 22 | $2.01M |
| Q3 2024 | 21 | $3.46M |
| Q2 2024 | 36 | $4.77M |
| Q1 2024 | 46 | $17.1M |
| Q4 2023 | 35 | $3.02M |
| Q3 2023 | 39 | $24.2M |
| Q2 2023 | 35 | $40.6M |
| Q1 2023 | 17 | $47.6M |
| Q4 2022 | 43 | $108.1M |
| Q3 2022 | 40 | $105.9M |
| Q2 2022 | 35 | $102.9M |
| Q1 2022 | 34 | $99.4M |
| Q4 2021 | 26 | $81.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Ocean Biomedical, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Polar Asset Management Partners Inc. | 2,688,193 | $2.59M | 0.06% | 00.0% | Unchanged |
| Vanguard Group Inc | 406,529 | $398.4K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 140,991 | $138.2K | 0.00% | −1,910−1.3% | Reduced |
| Millennium Management LLC | 127,562 | $125.0K | 0.00% | −40,571−24.1% | Reduced |
| BlackRock, Inc. | 60,751 | $59.5K | 0.00% | +60,751 | New |
| Citadel Advisors LLC | 32,908 | $32.3K | 0.00% | +32,908 | New |
| State Street Corp | 32,800 | $32.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 26,775 | $26.2K | 0.00% | −51,438−65.8% | Reduced |
| Bank of Montreal | 20,000 | $19.8K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 18,562 | $18.2K | 0.00% | +18,562 | New |
| ACT Advisors, LLC. | 16,701 | $16.4K | 0.01% | +69+0.4% | Added |
| Tower Research Capital LLC (TRC) | 4,583 | $4.49K | 0.00% | −5,603−55.0% | Reduced |
| FMR LLC | 2,439 | $2.39K | 0.00% | −5,806−70.4% | Reduced |
| Nordwand Advisors, LLC | 2,000 | $1.96K | 0.00% | +2,000 | New |
| Citigroup Inc | 791 | $775 | 0.00% | −2,304−74.4% | Reduced |
| Morgan Stanley | 399 | $391 | 0.00% | −15,881−97.5% | Reduced |
| Bank of America Corp | 229 | $224 | 0.00% | −53−18.8% | Reduced |
| JPMorgan Chase & Co | 209 | $205 | 0.00% | −1,546−88.1% | Reduced |
| Farther Finance Advisors, LLC | 183 | $179 | 0.00% | +1+0.5% | Added |
| UBS Group AG | 152 | $149 | 0.00% | −2,483−94.2% | Reduced |
| FNY Investment Advisers, LLC | 600 | $0 | 0.00% | −200−25.0% | Reduced |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −64,985−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −58,159−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −34,642−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −24,300−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −22,852−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −17,800−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −12,047−100.0% | Sold out |
| Mariner, LLC | 0 | $0 | 0.00% | −10,603−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −8,639−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −4,881−100.0% | Sold out |
| Rhumbline Advisers | 0 | $0 | 0.00% | −876−100.0% | Sold out |
| The PNC Financial Services Group, Inc. | 0 | $0 | 0.00% | −764−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −478−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −447−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −32−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |